Karyopharm Therapeutics Inc.
KPTI
DELAYED 1 MONTH
19 insider filings · Latest: Jul 28, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 28, 2026 | Jul 30 8:42 PM | Stuart PoultonEVP, Chief Development Officer | Sale | 189 | $7.10 | $1.3K | 94,632(D) | View → |
| May 14, 2026 | May 15 8:08 PM | Stuart PoultonEVP, Chief Development Officer | Sale | 403 | $9.50 | $3.8K | 94,821(D) | View → |
| May 14, 2026 | May 15 8:07 PM | Reshma RangwalaEVP & Chief Medical Officer | Sale | 408 | $9.50 | $3.9K | 56,829(D) | View → |
| May 14, 2026 | May 15 8:05 PM | Sohanya Roshan ChengEVP & Chief Commercial Officer | Sale | 324 | $9.50 | $3.1K | 107,940(D) | View → |
| May 14, 2026 | May 15 8:04 PM | Kristin AbateChief Accounting Officer | Sale | 53 | $9.50 | $504 | 23,801(D) | View → |
| May 14, 2026 | May 15 8:03 PM | Richard A. PaulsonDirector, President and CEO | Sale | 2,203 | $9.50 | $20.9K | 269,747(D) | View → |
| May 14, 2026 | May 15 8:02 PM | Michael ManoEVP, CLO&Secretary | Sale | 266 | $9.50 | $2.5K | 94,398(D) | View → |
| Mar 2, 2026 | Mar 3 9:29 PM | Kristin AbateChief Accounting Officer | Sale | 559 | $9.41 | $5.3K | 22,063(D) | View → |
| Mar 2, 2026 | Mar 3 9:28 PM | Michael ManoEVP, CLO&Secretary | Sale | 3,526 | $9.41 | $33.2K | 93,964(D) | View → |
| Mar 2, 2026 | Mar 3 9:27 PM | Sohanya Roshan ChengEVP & Chief Commercial Officer | Sale | 4,604 | $9.41 | $43.3K | 107,317(D) | View → |
| Mar 2, 2026 | Mar 3 9:25 PM | Reshma RangwalaEVP & Chief Medical Officer | Sale | 5,066 | $9.41 | $47.7K | 56,739(D) | View → |
| Mar 2, 2026 | Mar 3 9:21 PM | Richard A. PaulsonDirector, President and CEO | Sale | 12,361 | $9.41 | $116.3K | 267,030(D) | View → |
| Mar 2, 2026 | Mar 3 9:17 PM | Stuart PoultonEVP, Chief Development Officer | Sale | 5,101 | $9.41 | $48.0K | 94,328(D) | View → |
Stock Options & Derivatives
No transactions found.